Expression, Tissue Distribution and Function of MiR-21 in Esophageal Squamous Cell Carcinoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Sep 17

PMID 24039846

Citations 60

Authors

Nazila Nouraee

Katrien Van Roosbroeck

Mohammad Vasei

Shahriar Semnani

Nader Mansour Samaei

Farshad Naghshvar

Abbas Ali Omidi

George A Calin

Seyed Javad Mowla

Affiliations

Soon will be listed here.

Abstract

Objective: MiR-21 is an oncomir expressed by malignant cells and/or tumor microenvironment components. In this study we focused on understanding the effects of stromal miR-21 on esophageal malignant cells.

Design: MiR-21 expression was evaluated in formalin-fixed paraffin-embedded samples from patients with esophageal squamous-cell carcinoma (SCC) by quantitative RT-PCR. MiR-21 tissue distribution was visualized with in situ hybridization. A co-culture system of normal fibroblasts and esophageal cancer cells was used to determine the effects of fibroblasts on miR-21 expression levels, and on SCC cell migration and invasion.

Results: MiR-21 was overexpressed in SCCs, when compared to the adjacent non-tumor tissues (P = 0.0007), and was mainly localized in the cytoplasm of stromal cells adjacent to malignant cells. Accordingly, miR-21 expression was increased in tumors with high versus low stromal content (P = 0.04). When co-cultured with normal fibroblasts, miR-21 expression was elevated in SCC cells (KYSE-30), while its expression was restricted to fibroblasts when co-cultured with adenocarcinoma cells (OE-33 and FLO-1). MiR-21 was detected in conditioned media of cancer cell lines, illustrating the release of this miRNA into the environment. Co-culturing with normal fibroblasts or addition of fibroblast conditioned media caused a significant increase in cell migration and invasion potency of KYSE-30 cells (P<0.0001). In addition, co-culturing cancer cells with fibroblasts and expression of miR-21 induced the expression of the cancer associated fibroblast (CAF) marker S100A4.

Conclusions: MiR-21 expression is mostly confined to the SCC stroma and its release from fibroblasts influences the migration and invasion capacity of SCC cells. Moreover, miR-21 may be an important factor in "activating" fibroblasts to CAFs. These findings provide new insights into the role of CAFs and the extracellular matrix in tumor microenvironment formation and in tumor cell maintenance, and suggest miR-21 may contribute to cellular crosstalk in the tumor microenvironment.

Citing Articles

Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery.

Al-Ani S, Lee Q, Maheswaran D, Sin Y, Loh J, Foo J Mol Biotechnol. 2024; .

PMID: 39269575 DOI: 10.1007/s12033-024-01268-6.

Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4.

Hu X, Ye Q, Lu H, Wu Z, Chen S, Zheng R Clin Epigenetics. 2024; 16(1):81.

PMID: 38890707 PMC: 11184720. DOI: 10.1186/s13148-024-01685-z.

Interplay of miR-542, miR-126, miR-143 and miR-26b with PI3K-Akt is a Diagnostic Signal and Putative Regulatory Target in HPV-Positive Cervical Cancer.

Rahimi-Moghaddam A, Ghorbanmehr N, Gharbi S, Nili F, Korsching E Biochem Genet. 2024; .

PMID: 38849709 DOI: 10.1007/s10528-024-10837-y.

The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs.

Stabile R, Cabezas M, Verhagen M, Tucci F, van den Bosch T, De Herdt M Cell Death Dis. 2023; 14(5):337.

PMID: 37217493 PMC: 10202934. DOI: 10.1038/s41419-023-05857-2.

Synthetic miR-21 decoy circularized by tRNA splicing mechanism inhibited tumorigenesis in glioblastoma and models.

Bayat H, Pourgholami M, Rahmani S, Pournajaf S, Mowla S Mol Ther Nucleic Acids. 2023; 32:432-444.

PMID: 37181451 PMC: 10173299. DOI: 10.1016/j.omtn.2023.04.001.

References

Bozoky B, Savchenko A, Csermely P, Korcsmaros T, Dul Z, Ponten F . Novel signatures of cancer-associated fibroblasts. Int J Cancer. 2013; 133(2):286-93. DOI: 10.1002/ijc.28035. View

Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

Patnaik S, Mallick R, Yendamuri S . MicroRNAs and esophageal cancer. J Gastrointest Oncol. 2012; 1(1):55-63. PMC: 3397565. DOI: 10.3978/j.issn.2078-6891.2010.011. View

Stover D, Bierie B, Moses H . A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem. 2007; 101(4):851-61. DOI: 10.1002/jcb.21149. View

Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y . MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res. 2009; 15(6):1915-22. DOI: 10.1158/1078-0432.CCR-08-2545. View

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S . Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 2010; 23(6):1625-33. DOI: 10.3892/or_00000804. View

Jorgensen S, Baker A, Moller S, Nielsen B . Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods. 2010; 52(4):375-81. DOI: 10.1016/j.ymeth.2010.07.002. View

Tejani M, Burtness B . Multi-modality therapy for cancer of the esophagus and GE junction. Curr Treat Options Oncol. 2012; 13(3):390-402. DOI: 10.1007/s11864-012-0193-5. View

Cirri P, Chiarugi P . Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res. 2011; 1(4):482-97. PMC: 3186047. View

10.

Song J . EMT or apoptosis: a decision for TGF-beta. Cell Res. 2007; 17(4):289-90. DOI: 10.1038/cr.2007.25. View

11.

Yang C, Yue J, Pfeffer S, Handorf C, Pfeffer L . MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem. 2011; 286(45):39172-8. PMC: 3234742. DOI: 10.1074/jbc.M111.285098. View

12.

Qi L, Bart J, Tan L, Platteel I, van der Sluis T, Huitema S . Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer. 2009; 9:163. PMC: 2695476. DOI: 10.1186/1471-2407-9-163. View

13.

Mase Y, Ishibashi O, Ishikawa T, Takizawa T, Kiguchi K, Ohba T . MiR-21 is enriched in the RNA-induced silencing complex and targets COL4A1 in human granulosa cell lines. Reprod Sci. 2012; 19(10):1030-40. DOI: 10.1177/1933719112442245. View

14.

Mathe E, Nguyen G, Bowman E, Zhao Y, Budhu A, Schetter A . MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res. 2009; 15(19):6192-200. PMC: 2933109. DOI: 10.1158/1078-0432.CCR-09-1467. View

15.

Delgado M, Leon J . Gene expression regulation and cancer. Clin Transl Oncol. 2006; 8(11):780-7. DOI: 10.1007/s12094-006-0132-7. View

16.

Willis B, Borok Z . TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007; 293(3):L525-34. DOI: 10.1152/ajplung.00163.2007. View

17.

Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffetta P, Malekzadeh R . Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer. 2009; 45(18):3156-65. DOI: 10.1016/j.ejca.2009.09.018. View

18.

Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5):392-401. DOI: 10.1038/nrc1877. View

19.

Selcuklu S, Donoghue M, Spillane C . miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans. 2009; 37(Pt 4):918-25. DOI: 10.1042/BST0370918. View

20.

Yang Y, Pan X, Lei W, Wang J, Song J . Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene. 2006; 25(55):7235-44. DOI: 10.1038/sj.onc.1209712. View